person

Manuela B.

Country
Italy
Department
S.S.D. Microcitemia e delle Anemie Congenite

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
50
Sites with multiple studies

Has run more than one trial at 50 of 98 partner sites.

Specializations

Thalassemia Research

The investigator specializes in both transfusion-dependent and non-transfusion-dependent thalassemia, with particular focus on treating alpha and beta thalassemia variants. Their research encompasses innovative therapeutic approaches for managing thalassemia-related complications.

  • Alpha-thalassemia treatment studies
  • Beta-thalassemia management approaches
  • Transfusion dependency interventions

The work extends to pediatric and adult populations, investigating novel compounds for improving anemia outcomes.

Sickle Cell Disease Studies

The investigator conducts research in sickle cell disease treatment, focusing on addressing both anemia and pain crises. Their work includes evaluation of oral therapeutics and novel treatment approaches for patients who cannot use conventional treatments.

  • Anemia management in SCD
  • Pain crisis intervention
  • Alternative therapeutic options

Research emphasis includes developing treatments for patients with limited therapeutic options.

Rare Blood Disorders

The investigator's expertise extends to rare conditions including Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP). Their research includes long-term safety studies and therapeutic interventions for managing sun exposure sensitivity.

  • EPP treatment development
  • Iron overload management
  • Long-term therapeutic monitoring

The research focuses on improving quality of life for patients with these rare conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.